Antigenic proteins of shrimp white spot syndrome virus and uses thereof
AssigneeAkzo Nobel N.V.
InventorsJustinus Maria Vlak, Maria Cornelia Wilhelmina Van Hulten
Life of this patent
Estimating the term…
Abstract
The present invention relates to antigenic proteins derived from White Spot Syndrome virus having an estimated size of 19 kDa (VP 19) or 13 kDA (VP13), to the use of these proteins in vaccines and to vaccines on the basis of these proteins. Furthermore, the invention relates to antibodies against these proteins and to the use of antibodies in vaccines, to nucleic acid sequences encoding these proteins and to their use in vaccines. Also, the invention relates to the use of said proteins in the manufacture of a vaccine for prophylaxis and/or treatment of White Spot Syndrome in crustaceans, to vector vaccines and to diagnostic kits comprising said nuclei acids or antibodies.
Claims12
1) Antigenic protein of WSSV suitable for immunising crustaceans against WSSV, characterised in that said antigenic protein has an amino acid sequence that is at least 70% homologous to the amino acid sequence as depicted in SEQ ID NO:
- 2, SEQ ID NO:
- 4 or SEQ ID NO:
- 5 or an immunogenic fragment of said antigenic protein.
Dependencies are inferred from the claim text.